ALDOB and obesity disorder: Obesity and liver pathology have been linked to fructose metabolic processing and an upregulation of Aldob (Stocks et al., 2022), suggesting that Ch‐ may induce obesity and liver pathology phenotypes, leading to the upregulation of these proteins.